<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02720393</url>
  </required_header>
  <id_info>
    <org_study_id>2015-1255</org_study_id>
    <nct_id>NCT02720393</nct_id>
  </id_info>
  <brief_title>Impact of No-carrageenan Diet on Glucose Tolerance in Prediabetes</brief_title>
  <official_title>Impact of no Carrageenan Diet on Glucose Tolerance in Prediabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Illinois at Chicago</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Participants will be randomly assigned to either regular or no-carrageenan prepared diets to
      determine whether the no-carrageenan leads to improvement in glucose tolerance. Hemoglobin
      A1c is the primary outcome measure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will be randomly assigned to a diet. They will at onset have hemoglobin A1c values
      between 5.7% and 6.4%. Baseline glucose tolerance test will be performed, as well as measures
      of inflammation and fecal microbiome. Interim tests will be performed at six weeks. Subjects
      will participate for 12 weeks, at which time they will be re-evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in hemoglobin A1c</measure>
    <time_frame>baseline, 12 weeks</time_frame>
    <description>Measurements performed after 12 weeks of dietary intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in serum Interleukin-8</measure>
    <time_frame>baseline, 12 weeks</time_frame>
    <description>Impact of diet on serum Interleukin-8</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact on glucose tolerance test</measure>
    <time_frame>12 weeks</time_frame>
    <description>perform repeat oral glucose tolerance test after 12 weeks of dietary intervention</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact on insulin level</measure>
    <time_frame>12 weeks</time_frame>
    <description>determine effect of dietary intervention on insulin level at the time of glucose tolerance test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in leukocyte subsets</measure>
    <time_frame>baseline, 12 weeks</time_frame>
    <description>determine if there is change in distribution of leukocyte subsets from blood samples of study participants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Tumor Necrosis Factor-alpha in serum</measure>
    <time_frame>baseline, 12 weeks</time_frame>
    <description>determine if there is change in circulating TNF-alpha in blood samples</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in insulin signaling pathway</measure>
    <time_frame>baseline, 12 weeks</time_frame>
    <description>determine if there are changes in activation of intermediates in insulin signaling pathway in circulating leukocytes following dietary intervention</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in fecal microbiome</measure>
    <time_frame>baseline, 12 weeks</time_frame>
    <description>Impact of diet on fecal microbiome following dietary intervention determined by whole genome sequencing of fecal bacteria</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in fecal calprotectin</measure>
    <time_frame>baseline, 12 weeks</time_frame>
    <description>determine effect of dietary intervention on fecal calprotectin</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Prediabetes</condition>
  <arm_group>
    <arm_group_label>Regular diet</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Meals and snacks will contain carrageenan in the amount consumed in the typical daily diet and will be selected by the study dietician and distributed to study subjects randomized to the regular diet study arm.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No-carrageenan diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No-carrageenan diet will be composed of meals and snacks selected by the study dietician and distributed to study participants who are randomized to the no-carrageenan diet study arm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No-carrageenan diet</intervention_name>
    <description>Diet of food items that have no carrageenan as selected by study dietician.</description>
    <arm_group_label>No-carrageenan diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Regular Diet</intervention_name>
    <description>Diet of food items that have carrageenan as selected by study dietician</description>
    <arm_group_label>Regular diet</arm_group_label>
    <other_name>Carrageenan-containing diet</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  per diabetes, ability to follow diet and study procedures

        Exclusion Criteria:

          -  on any medications that affect glucose, medical conditions or allergies that affect
             adherence to study diet, pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mitra Dutta, Ph.D.</last_name>
    <phone>312-996-4995</phone>
    <email>awards@uic.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Illinois at Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joanne K. Tobacman, M.D.</last_name>
      <phone>312-569-7826</phone>
      <email>jkt@uic.edu</email>
    </contact>
    <investigator>
      <last_name>Joanne K. Tobacman, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Krista Varady, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2016</study_first_submitted>
  <study_first_submitted_qc>March 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 25, 2016</study_first_posted>
  <last_update_submitted>October 24, 2016</last_update_submitted>
  <last_update_submitted_qc>October 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Illinois at Chicago</investigator_affiliation>
    <investigator_full_name>Joanne Kramer Tobacman</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>If required, individual data without identifiers may be made available.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

